Bevacizumab-Teva 100 mg/4 ml, Konzentrat zur Herstellung einer Infusionslösung
7680678860019
CH-67886
Konzentrat
Associated product:
BEVACIZUMAB Teva conc perf 100 mg/4ml flac
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Konzentrat
- Galenic group
- Tinkturen/Desinfektion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
5.44 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 296.55
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/07/2021
Authorization holder
Teva Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 67886
- Drug name
- Bevacizumab-Teva, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L01FG01
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 10/05/2021
- Authorization expiration date
- 31/12/9999
- IT Number
- 07.16.1.
- Domain
- Human medicine
Package details
- Description (FR)
- BEVACIZUMAB Teva conc perf 100 mg/4ml flac
- Description (DE)
- BEVACIZUMAB Teva Inf Konz 100 mg/4ml Durchstf
- Market launch
- 10/05/2021
- Narcotic (BTM)
- No
Other package sizes (1)
BEVACIZUMAB Teva conc perf 400 mg/16ml flac
1 DUR
GTIN: 7680678860026